Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. - Wikidata - awgldk - TriplyDB

Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.

Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.

http://www.wikidata.org/entity/Q39506058

about

Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?ESAT-6/CFP10 skin test predicts disease in M. tuberculosis-infected guinea pigs.Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.Antigen specificity in experimental bovine tuberculosis.Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.Diagnostic implications of antigen-induced gamma interferon production by blood leukocytes from Mycobacterium bovis-infected reindeer (Rangifer tarandus).ESAT-6 peptide recognition by bovine CD8+ lymphocytes of naturally infected cows in herds from southern Italy.Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes Efficacy of a vaccine formula against tuberculosis in cattle.New skin test for detection of bovine tuberculosis on the basis of antigen-displaying polyester inclusions produced by recombinant Escherichia coli.Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle.Optimizing antigen cocktails for detection of Mycobacterium bovis in herds with different prevalences of bovine tuberculosis: ESAT6-CFP10 mixture shows optimal sensitivity and specificity.Diagnostic implications of antigen-induced gamma interferon, nitric oxide, and tumor necrosis factor alpha production by peripheral blood mononuclear cells from Mycobacterium bovis-infected cattle Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis Subcutaneous administration of a 10-fold-lower dose of a commercial human tuberculosis vaccine, Mycobacterium bovis bacillus Calmette-Guerin Danish, induced levels of protection against bovine tuberculosis and responses in the tuberculin intradermal Increased TNF-α/IFN-γ/IL-2 and Decreased TNF-α/IFN-γ Production by Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis Following BCG Vaccination.Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection.Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis.A polymerase chain reaction and enzyme linked immunosorbent assay based approach for diagnosis and differentiation between vaccinated and infected cattle with Mycobacterium bovis Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide.Performance of the Enferplex TB assay with cattle in Great Britain and assessment of its suitability as a test to distinguish infected and vaccinated animals.Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis.Display of Antigens on Polyester Inclusions Lowers the Antigen Concentration Required for a Bovine Tuberculosis Skin Test Specificity of the tuberculin skin test is modified by use of a protein cocktail containing ESAT-6 and CFP-10 in cattle naturally infected with Mycobacterium bovis.Minimum infective dose of Mycobacterium bovis in cattle.Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane.Cattle husbandry in Ethiopia is a predominant factor affecting the pathology of bovine tuberculosis and gamma interferon responses to mycobacterial antigens.Antigen mining with iterative genome screens identifies novel diagnostics for the Mycobacterium tuberculosis complex.Development and evaluation of an interferon gamma assay for the diagnosis of tuberculosis in red deer experimentally infected with Mycobacterium bovis.Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.Next-Generation Vaccines Based on Bacille Calmette-Guérin.

P2860

Q28083050-FC71D489-F945-4886-AD35-FE5AB30E0DB1 Q33330264-814BE600-BC64-4575-9F67-B2B615D9D712 Q33592353-5CEE8BD8-A866-4B26-89D7-276DFEC007F2 Q33600356-39E33D7D-091A-4A97-8921-1DE1BE9D1EDE Q33998194-29F6551B-8097-4DDC-8444-76826FE17B28 Q33999132-9269EA04-EFDD-4AF4-B801-98A0ED6B3C39 Q34004194-4B4A978B-938C-43A2-85C6-112E201FDE43 Q34120518-6D60C99C-ABA5-4426-A00B-7CBA687B5BE6 Q34184039-1CD984BE-7A49-4C36-A666-5919AF15190C Q34257884-88B22C04-4E66-4D57-868C-7F37EF018D03 Q34325866-4B233958-AC0F-43C3-8DB5-93333E5477DC Q34601469-3976828B-14F9-4EF9-9D5E-3B2F7CD3971F Q34739101-6B1AF15F-F1C5-4D14-A32B-77EE552BBD91 Q34853954-530C2FAF-C67C-4A18-A341-8A89178F5136 Q35034673-BBD1A0A2-A6F6-4895-88B3-6743A9369D24 Q35095115-5AF8DB3E-B5C8-41FB-A7C6-6BE0EE9B794C Q35216135-36E79824-C2B8-4CCC-AB8C-2CC8FF522CE1 Q35221002-AAE2D8F2-22EA-434C-85E1-E7678F610CD9 Q35923290-82A97BF8-337B-4796-BA91-7B35C1C5B1CA Q36672533-D2DD3789-4096-41C7-B3C2-46A61011FF56 Q37059722-C258A3AD-1FED-448B-BAE7-5B55EDCB0181 Q37252327-C1E3B342-9BEA-40C3-80C9-B0D3FB026598 Q37342751-34B6F122-51CD-432C-BD22-C81510019D3A Q37426577-6B218C3A-857F-4B8C-B8EC-641248F9E5FF Q37582898-6AA5CAE3-9C4B-4DC4-B854-B3FEC4A847FC Q37698070-AFA098E4-09BB-4287-9109-826E8061BD1B Q39655276-FFA2E64A-9ABD-4481-B0B6-FF3BD36AD5CD Q39981959-28D704FE-A6D4-441B-BC2B-246A7F60BF92 Q40326247-102A9C02-BDF6-4B99-A1D2-CE49D3AED9B5 Q40545644-3EAA7AC9-D714-457F-AE99-084BE7A9B7F9 Q40763818-4489507B-6A50-4C8B-92FC-1890BB2DAD1D Q40933335-B185F4AD-3F98-426D-B9C2-F21696C2190C Q42102986-BE91CE00-A9F3-4C06-A1CE-E0C66AFFF41C Q42113447-EC0F48F5-A033-4261-9312-3F9C079B7203 Q42373964-AD8FCF03-6868-4590-ABCA-5ECC908321E3 Q43152700-9C52C9F1-9BEA-41D4-B6AC-869E426F557F Q43192973-D105D16E-7BE1-4AFF-8620-9DD965D5F042 Q45910307-AC4BBC50-FC35-441F-ABA0-97564418476C Q47624803-91FC1180-6E88-451D-9F62-8FAE328C2FA6 Q49829375-DBEC6F06-DA41-49F3-9AF9-447098772C03

P2860

Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.

http://www.wikidata.org/entity/Q39506058

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Differentiation between Mycoba ...... binant mycobacterial antigens.

@en

Differentiation between Mycoba ...... binant mycobacterial antigens.

@nl

type

label

Differentiation between Mycoba ...... binant mycobacterial antigens.

@en

Differentiation between Mycoba ...... binant mycobacterial antigens.

@nl

prefLabel

Differentiation between Mycoba ...... binant mycobacterial antigens.

@en

Differentiation between Mycoba ...... binant mycobacterial antigens.

@nl

P1433

Q39506058-5A606571-7ABE-42DC-8E71-BFE256A14DEA

P1476

Q39506058-65444707-1CC7-4671-9BBB-6431807FA475

P2093

Q39506058-07DFEBD9-3F46-4C39-89DB-B21717F01691

Q39506058-0A28CC52-A396-49FC-8C57-D94C0C477AB6

Q39506058-3248BFB8-4B49-45B1-B5F6-7110B31414F7

Q39506058-7FB38F22-F5DB-49F3-8EBC-D0DE6D422868

Q39506058-9E6BFE18-7607-427B-8506-357A80124612

Q39506058-B4CBA7FB-B09A-4632-9A81-EC86CF5CFE46

Q39506058-C141E961-F084-4648-AE51-F9397F8CB039

P2860

Q39506058-0C59EB0F-897F-4C93-B7A2-33669EDFE953

Q39506058-18E808E0-1BB5-4AD9-97A8-4682AA0E26E4

Q39506058-24A3B7D3-3611-4CF8-A0AC-4C004D8B293A

Q39506058-28B45BCB-5F6A-4788-9A65-A87D225546BA

Q39506058-2F124DA4-D7D6-4DAC-B684-20837F0D77DD

Q39506058-4147D0DE-2C4A-4AF9-B80A-950D12746B7F

Q39506058-630D59EE-7CBE-4261-8C23-36ED7E9DCD90

Q39506058-6C427A8D-2CFC-4733-B168-FDD3CE54D912

Q39506058-8BBD5248-7C12-4A1B-A8A2-411C85502151

Q39506058-983A7D09-6A0A-414D-A856-6EEBB12F9199

P304

Q39506058-E3CCEED4-1CCB-4105-9069-1E75580A0F9D

P31

Q39506058-0C0E67E1-21FC-44D4-B2B1-AA2002DA933E

P433

Q39506058-4A1FE036-270B-4FC0-9FF8-DDDEDF17F1DC

P478

Q39506058-B142218E-B383-4043-88AC-0B87B8DE558F

P577

Q39506058-C5A0F60C-99E5-4747-AEC6-39F3EF2BA423

P698

Q39506058-B0B954DA-D046-40A6-B383-090B54D81FB9

P932

Q39506058-9541EB44-7477-4C0E-97D0-E7513F91C683

P1433

Clinical and Vaccine Immunology

P1476

Differentiation between Mycoba ...... mbinant mycobacterial antigens

@en

P2093

B M Buddle

http://www.w3.org/2001/XMLSchema#string

D L Keen

http://www.w3.org/2001/XMLSchema#string

F E Aldwell

http://www.w3.org/2001/XMLSchema#string

J M Pollock

http://www.w3.org/2001/XMLSchema#string

K Lightbody

http://www.w3.org/2001/XMLSchema#string

N A Parlane

http://www.w3.org/2001/XMLSchema#string

P Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

HIV/AIDS and its implications for the control of animal tuberculosis.

Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG

B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis

The epidemiology of Mycobacterium bovis infections in animals and man: a review.

Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG.

Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle.

Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv

Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9874655

http://www.w3.org/2001/XMLSchema#string

P932

95651

http://www.w3.org/2001/XMLSchema#string